Ethical Compliance
MEDICAMEN BIOTECH
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
0.4%
Debt
10.5%
Liquidity
5%
Revenue
Debt
Liquidity
0.4%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharmaceuticals | ₹177.88 |
| Other Operating Revenue | ₹1.43 |
| Other Income | ₹1.60 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹0.72 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹0.72 |
| Total: | ₹0.72 |
| Total Revenue: | ₹181.63 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹0.72
₹181.63
= 0.4%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
